CATALOGO DEI PRODOTTI DELLA RICERCA

IDOLAZZI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.231
EU - Europa 8.591
AS - Asia 5.956
SA - Sud America 839
AF - Africa 172
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 9
Totale 24.812
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.066
RU - Federazione Russa 3.023
SG - Singapore 2.328
GB - Regno Unito 2.154
CN - Cina 1.939
IT - Italia 814
BR - Brasile 664
DE - Germania 640
SE - Svezia 486
VN - Vietnam 473
HK - Hong Kong 444
FR - Francia 431
IE - Irlanda 393
FI - Finlandia 268
KR - Corea 186
IN - India 118
JP - Giappone 101
TR - Turchia 101
UA - Ucraina 90
CA - Canada 82
AR - Argentina 71
NL - Olanda 69
BD - Bangladesh 62
MX - Messico 51
PL - Polonia 43
ZA - Sudafrica 43
NG - Nigeria 42
ID - Indonesia 36
ES - Italia 32
BE - Belgio 31
AT - Austria 30
EC - Ecuador 27
IQ - Iraq 25
RO - Romania 20
CO - Colombia 19
UZ - Uzbekistan 19
SA - Arabia Saudita 17
VE - Venezuela 17
EG - Egitto 16
IR - Iran 14
CL - Cile 12
KE - Kenya 12
MA - Marocco 12
PE - Perù 12
PK - Pakistan 12
AU - Australia 10
BJ - Benin 10
PY - Paraguay 10
PH - Filippine 8
NP - Nepal 7
QA - Qatar 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
CH - Svizzera 6
ET - Etiopia 6
GR - Grecia 6
IL - Israele 6
LT - Lituania 6
SN - Senegal 6
AL - Albania 5
CR - Costa Rica 5
CZ - Repubblica Ceca 5
JM - Giamaica 5
JO - Giordania 5
NO - Norvegia 5
TN - Tunisia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
EU - Europa 4
HR - Croazia 4
KG - Kirghizistan 4
LB - Libano 4
MY - Malesia 4
PA - Panama 4
SV - El Salvador 4
TG - Togo 4
AM - Armenia 3
BG - Bulgaria 3
BY - Bielorussia 3
DK - Danimarca 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
PT - Portogallo 3
RS - Serbia 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
AF - Afghanistan, Repubblica islamica di 2
BH - Bahrain 2
BO - Bolivia 2
BW - Botswana 2
CU - Cuba 2
GT - Guatemala 2
IS - Islanda 2
LV - Lettonia 2
OM - Oman 2
SO - Somalia 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
Totale 24.781
Salva come PNG Salva come JPEG
Città #
Southend 1.927
Dallas 1.564
Singapore 1.270
Ashburn 1.033
Moscow 1.019
Chandler 942
San Jose 802
Jacksonville 471
Hong Kong 432
Dublin 392
Woodbridge 390
Ann Arbor 315
Beijing 306
Verona 292
The Dalles 274
Houston 215
Lawrence 160
Los Angeles 160
Princeton 160
Wilmington 155
New York 154
Ho Chi Minh City 151
Jinan 145
Bologna 131
Redmond 128
Shenyang 127
Nanjing 122
Hanoi 107
Helsinki 97
Tokyo 90
Munich 83
Buffalo 79
Hebei 73
Tianjin 73
São Paulo 66
Redondo Beach 57
Zhengzhou 56
Changsha 52
Haikou 51
Ningbo 51
Milan 49
Santa Clara 48
Columbus 45
Sindelfingen 43
Taizhou 43
Hangzhou 42
Guangzhou 41
Abuja 40
Orem 40
Taiyuan 39
Nanchang 38
Warsaw 36
Montreal 35
Chicago 34
Redwood City 34
San Francisco 34
Jiaxing 32
Council Bluffs 31
Denver 31
London 31
Rome 31
Atlanta 28
Brooklyn 27
Brussels 26
Seattle 26
Turku 26
Johannesburg 25
Norwalk 25
Boardman 24
Lanzhou 24
Toronto 24
Fuzhou 23
Hyderabad 23
Amsterdam 22
Da Nang 22
Washington 22
Düsseldorf 21
Chennai 20
Manchester 20
Phoenix 20
Rio de Janeiro 20
Brasília 19
Dearborn 19
Frankfurt am Main 19
Mexico City 19
Vienna 19
Poplar 18
Sanayi 18
Stockholm 18
Tashkent 18
Haiphong 17
Lancaster 17
Venice 16
Belo Horizonte 15
Falls Church 15
Jakarta 15
Nürnberg 15
Orani 15
Porto Alegre 15
Falkenstein 14
Totale 15.758
Salva come PNG Salva come JPEG
Nome #
Italian Multicenter Real-World Study on the Twelve-Month Effectiveness, Safety, and Retention Rate of Guselkumab in Psoriatic Arthritis Patients 349
Teriparatide and denosumab combination therapy and skeletal metabolism 340
First-line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING-SIR registry 335
A new instrument for the screening of psoriatic arthritis among psoriatic patients 313
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 251
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 251
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 221
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 218
Bone metabolism in patients with anorexia nervosa and amenorrhoea 218
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 212
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 210
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 209
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 209
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 206
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' 206
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 205
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 205
A case of mandible Paget’s disease of the bone treated with intravenous neridronate 204
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 201
Bone involvement and osteoporosis in mastocytosis. 200
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 200
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 197
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 196
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 194
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 191
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 188
Prevalence and incidence of rheumatoid arthritis in Italy. 187
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 187
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 187
Bone involvement in patient with clonal mast cell disorders 186
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 186
Could γ\δ T-cells explain zoledronic acid adverse events? 186
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 184
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 183
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 181
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 181
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 179
Anti-TNF treatment response in rheumatoid arthritis patients with moderate disease activity: a prospective observational multicentre study (MODERATE) 178
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 175
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 174
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 171
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 169
DXA bone mineral density in males: retrospective study in real life. 166
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 166
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 165
Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis 164
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 164
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 163
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 162
Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome 160
Effects of denosumab on peripheral lymphocyte subpopulations 160
Sclerostin and DKK1 in primary hyperparathyroidism. 159
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 157
Prevalence of osteoporosis in patients affected by mastocytosis 156
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 155
Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis 155
Suboptimal methotrexate use in rheumatoid arthritis patients in Italy: the MARI study 154
The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions 154
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 154
Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosis 153
Correction to: The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions 153
Development and First Validation of a Disease Activity Score for Gout 152
Improvements in the management of rheumatic patients from vertebral imagee obtained through dual-energy X-ray absorptiometry. 151
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 151
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density 151
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 150
Periostin: The bone and beyond 150
Osteopetrosi 149
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 149
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 149
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 149
Operator-independent quantitative chest computed tomography versus standard assessment of interstitial lung disease related to systemic sclerosis: A multi-centric study 148
Surgical Treatment of Symptomatic Aortic Aneurysm in a Patient with Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis: Case Report and Review of the Literature 146
Relationship Between Increased Fecal Calprotectin Levels and Interstitial Lung Disease in Systemic Sclerosis 145
Focal bone involvement in inflammatory arthritis: the role of IL17 144
Drug-induced osteonecrosis of the jaw: the state of the art 144
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 143
Treatment of complex regional pain syndrome type I with neridronate: a randomized, double-blind, placebo-controlled study. 142
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 142
Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID) 142
Vitamin D levels in patients with psoriasis with or without arthritis 141
Rheumatoid arthritis, γδ T cells and bisphosphonates 140
The obesity paradox and osteoporosis 140
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis 139
Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa 137
Duration of treatment for osteoporosis 137
Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides? 136
Short-term effects on bone turnover markers of a single high dose of oral vitamin D₃. 135
Permanent Discontinuation of Glucocorticoids in Polymyalgia Rheumatica is Uncommon but May Be Enhanced by Amino Bisphosphonates 134
Enthesitis of the hands in psoriatic arthritis: an ultrasonographic perspective 134
Ruolo della vitamina D 133
MEDAL con etoricoxib: l’inizio di una nuova era per il trattamento del dolore muscolo scheletrico 133
Vitamin D status in patients with chronic plaque psoriasis 132
The negative bone effects of the disease and of chronic corticosteroid treatment in premenopausal women affected by rheumatoid arthritis 132
Effects of secukinumab on serum adipocytokines: preliminary data 132
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 131
Could nail and joint alterations make the difference between psoriatic arthritis and osteoarthritis during the ultrasonographic evaluation of the distal interphalangeal joints? 131
Predictors, Risk Factors, and Incidence Rates of Psoriatic Arthritis Development in Psoriasis Patients: A Systematic Literature Review and Meta-Analysis 131
Zoledronic Acid in Osteoporosis Secondary to Mastocytosis. 130
Quantitative chest computed tomography is associated with two prediction models of mortality in interstitial lung disease related to systemic sclerosis 130
Totale 17.328
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.278
article - articoli 78.212
book - libri 0
conference - conferenze 646
curatela - curatele 0
other - altro 420
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 158.556
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021161 0 0 0 0 0 0 0 0 0 11 107 43
2021/20221.206 93 347 7 62 54 29 24 65 81 24 85 335
2022/20232.688 191 289 242 491 213 650 45 145 291 30 76 25
2023/20241.251 54 113 107 152 158 180 60 126 6 37 189 69
2024/20253.160 152 221 152 493 145 111 163 147 472 262 282 560
2025/202610.774 720 506 1.661 1.661 2.545 710 1.060 554 791 566 0 0
Totale 25.156